Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)
China · Delayed Price · Currency is CNY 2.810
+0.040 (1.44%)
Jul 31, 2026, 3:00 PM CST
SHA:603363 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 429.85 | 697.57 | 1,384 | 207.66 | 719.08 | 542.98 |
Trading Asset Securities | 11 | 1.11 | 1.81 | 4.6 | 2.61 | 1 |
Cash & Short-Term Investments | 440.86 | 698.68 | 1,386 | 212.26 | 721.69 | 543.98 |
Cash Growth | -47.79% | -49.58% | 552.83% | -70.59% | 32.67% | -4.95% |
Accounts Receivable | 719.16 | 510.21 | 393.11 | 650.92 | 515.16 | 526.79 |
Other Receivables | 867.52 | 840.06 | 739.1 | 246.9 | 258.02 | 266.97 |
Receivables | 1,587 | 1,350 | 1,132 | 897.82 | 773.18 | 793.76 |
Inventory | 1,162 | 955.4 | 816.94 | 1,328 | 3,289 | 2,589 |
Prepaid Expenses | - | 0.05 | 0 | 0.08 | 0.03 | 0.04 |
Other Current Assets | 321.62 | 327.53 | 364.34 | 350.82 | 331.74 | 336.59 |
Total Current Assets | 3,511 | 3,332 | 3,699 | 2,789 | 5,115 | 4,263 |
Property, Plant & Equipment | 4,046 | 4,114 | 4,424 | 8,691 | 11,078 | 10,702 |
Long-Term Investments | 130.56 | 132.93 | 167.76 | 331.59 | 306.41 | 175.35 |
Goodwill | 337.74 | 337.74 | 345.39 | 386.31 | 439.17 | 488.51 |
Other Intangible Assets | 312.95 | 315.96 | 328.81 | 424.38 | 651.2 | 462.7 |
Long-Term Deferred Tax Assets | 136.84 | 142.63 | 142.07 | 166.89 | 253.22 | 150.77 |
Long-Term Deferred Charges | 165.93 | 167.82 | 159.57 | 335.89 | 354.11 | 320.94 |
Other Long-Term Assets | 209.63 | 199.15 | 239.13 | 499.99 | 466.2 | 536.96 |
Total Assets | 8,851 | 8,742 | 9,506 | 13,625 | 18,663 | 17,101 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,590 | 1,410 | 1,675 | 3,557 | 4,118 | 3,912 |
Accrued Expenses | 100.53 | 191.83 | 255.59 | 230.08 | 404.46 | 330.34 |
Short-Term Debt | 319.7 | 297.74 | 765.33 | 3,835 | 3,975 | 3,654 |
Current Portion of Long-Term Debt | 598.03 | 506.98 | 410.58 | 1,209 | 1,079 | 380.77 |
Current Portion of Leases | - | 72.59 | 94.54 | 662.62 | 813.06 | 702.36 |
Current Income Taxes Payable | 19.26 | 10.8 | 7 | 15.02 | 27.63 | 16.38 |
Current Unearned Revenue | 178.74 | 138.28 | 172.39 | 327.88 | 252.9 | 262.13 |
Other Current Liabilities | 971.62 | 937.5 | 1,234 | 1,523 | 975.74 | 858.49 |
Total Current Liabilities | 3,778 | 3,566 | 4,614 | 11,359 | 11,645 | 10,117 |
Long-Term Debt | 1,259 | 1,279 | 1,462 | 1,182 | 1,579 | 2,916 |
Long-Term Leases | 163.06 | 172.83 | 182.8 | 1,370 | 1,828 | 1,709 |
Long-Term Unearned Revenue | 97.4 | 99.64 | 108.73 | 173.05 | 149.2 | 109.36 |
Long-Term Deferred Tax Liabilities | 11.88 | 12.18 | 13.73 | 18.88 | 23.67 | 25.52 |
Other Long-Term Liabilities | 31.79 | 31.79 | 63.36 | 25.16 | 3.94 | 30.56 |
Total Liabilities | 5,341 | 5,162 | 6,445 | 14,128 | 15,229 | 14,908 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2,603 | 2,603 | 2,606 | 870.27 | 871.06 | 684.41 |
Additional Paid-In Capital | 5,456 | 5,475 | 5,004 | 3,776 | 3,664 | 1,535 |
Retained Earnings | -4,912 | -4,899 | -4,976 | -5,556 | -1,905 | -867.43 |
Treasury Stock | - | - | -17.56 | -17.46 | -81.9 | -158.81 |
Comprehensive Income & Other | -49.18 | -48.94 | -49.85 | -36.54 | -42.86 | 110.07 |
Total Common Equity | 3,098 | 3,130 | 2,566 | -962.97 | 2,506 | 1,303 |
Minority Interest | 411.79 | 449.73 | 494.97 | 459.75 | 929.26 | 889.52 |
Shareholders' Equity | 3,510 | 3,580 | 3,061 | -503.22 | 3,435 | 2,193 |
Total Liabilities & Equity | 8,851 | 8,742 | 9,506 | 13,625 | 18,663 | 17,101 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,340 | 2,329 | 2,915 | 8,259 | 9,273 | 9,362 |
Net Cash (Debt) | -1,899 | -1,631 | -1,530 | -8,047 | -8,552 | -8,818 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.85 | -0.63 | -1.77 | -9.28 | -11.04 | -13.58 |
Filing Date Shares Outstanding | 2,603 | 2,603 | 2,606 | 870.27 | 871.06 | 684.41 |
Total Common Shares Outstanding | 2,603 | 2,603 | 2,606 | 870.27 | 871.06 | 684.41 |
Working Capital | -266.58 | -234.01 | -914.89 | -8,570 | -6,530 | -5,854 |
Book Value Per Share | 1.19 | 1.20 | 0.98 | -1.11 | 2.88 | 1.69 |
Tangible Book Value | 2,447 | 2,477 | 1,892 | -1,774 | 1,415 | 352.26 |
Tangible Book Value Per Share | 0.94 | 0.95 | 0.73 | -2.04 | 1.62 | 0.30 |
Buildings | - | 3,017 | 3,102 | 4,825 | 4,827 | 4,170 |
Machinery | - | 2,012 | 2,094 | 3,162 | 3,131 | 2,686 |
Construction In Progress | - | 421.8 | 474.14 | 954.26 | 1,175 | 1,288 |